Jun activation domain-binding protein 1 expression in breast cancer inversely correlates with the cell cycle inhibitor p27(Kip1).

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Cancer Research

• Publication date

  2003-06-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 12782606
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The Cytoplasmic Shuttling and Subsequent Degradation of p27Kip1 Mediated by Jab1/CSN5 and the COP9 Signalosome Complex*

  2002cited by this paper
• High expression levels of p27 correlate with lymph node status in a subset of advanced invasive breast carcinomas

  2002influential reference
• Jab1 interacts directly with HIF-1alpha and regulates its stability.

  2002cited by this paper
• Intracrine hepatopoietin potentiates AP‐1 activity through JAB1 independent of MAPK pathway

  2002cited by this paper
• Jab1 antagonizes TGF-beta signaling by inducing Smad4 degradation.

  2002cited by this paper
• Heregulin induces expression, ATPase activity, and nuclear localization of G3BP, a Ras signaling component, in human breast tumors.

  2002cited by this paper
• Jab1 antagonizes TGF‐β signaling by inducing Smad4 degradation

  2002cited by this paper
• Jab1 Interacts Directly with HIF-1α and Regulates Its Stability*

  2002cited by this paper
• Expression of phosphorylated p27(Kip1) protein and Jun activation domain-binding protein 1 in human pituitary tumors.

  2002cited by this paper
• A complex situation

  2001cited by this paper
• COP9 signalosome revisited: a novel mediator of protein degradation.

  2001cited by this paper
• A mouse knock-in model exposes sequential proteolytic pathways that regulate p27Kip1 in G1 and S phase

  2001cited by this paper
• JAB1/CSN5 and the COP9 signalosome

  2001cited by this paper
• Jab1 expression is associated with inverse expression of p27(kip1) and poor prognosis in epithelial ovarian tumors.

  2001cited by this paper
• Intracellular action of the cytokine MIF to modulate AP-1 activity and the cell cycle through Jab1

  2000cited by this paper
• Integrin LFA-1 interacts with the transcriptional co-activator JAB1 to modulate AP-1 activity

  2000cited by this paper
• Transcriptional regulation of cell invasion: AP-1 regulation of a multigenic invasion programme.

  2000cited by this paper
• Biological and clinical associations of c‐jun activation in human breast cancer

  2000cited by this paper
• Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation.

  1999cited by this paper
• Degradation of the cyclin-dependent-kinase inhibitor p27Kip1 is instigated by Jab1

  1999cited by this paper
• Anomalous high p27/KIP1 expression in a subset of aggressive B-cell lymphomas is associated with cyclin D3 overexpression. p27/KIP1-cyclin D3 colocalization in tumor cells.

  1999cited by this paper
• CDK inhibitors: positive and negative regulators of G1-phase progression.

  1999cited by this paper
• cJun overexpression in MCF-7 breast cancer cells produces a tumorigenic, invasive and hormone resistant phenotype

  1999cited by this paper
• A novel protein complex involved in signal transduction possessing similarities to 26S proteasome subunits

  1998cited by this paper
• Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer

  1997cited by this paper
• Cyclin E-CDK2 is a regulator of p27Kip1.

  1997cited by this paper
• Phosphorylation‐dependent degradation of the cyclin‐dependent kinase inhibitor p27Kip1

  1997cited by this paper
• A new group of conserved coactivators that increase the specificity of AP-1 transcription factors

  1996influential reference
• Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27.

  1995cited by this paper
• Cloning of p27Kip1, a cyclin-dependent kinase inhibitor and a potential mediator of extracellular antimitogenic signals.

  1994cited by this paper

• CSN5 overexpression promotes the integral progression of cervical cancer by enhancing ENO3-mediated glycolysis

  2026cites this paper
• Targeting the COP9 signalosome overcomes platinum resistance in ovarian cancer through two distinct genome stability mechanisms

  2025cites this paper
• Identification and validation of a prognostic model for HER2-low breast cancer based on unfolded protein response-related genes

  2025cites this paper
• The CSN5/HSF/SPI1/PU.1 Axis Regulates Cell Proliferation in Hypocellular Myelodysplastic Syndrome Patients

  2023cites this paper
• Pan-cancer analyses of Jab1/COPS5 reveal oncogenic role and clinical outcome in human cancer

  2022cites this paper
• Identification of miRNA biomarkers for breast cancer by combining ensemble regularized multinomial logistic regression and Cox regression

  2022cites this paper
• Identification of a seven-long non-coding RNA signature associated with Jab1/CSN5 in predicting hepatocellular carcinoma

  2021cites this paper
• Signaling of MK2 sustains robust AP1 activity for triple negative breast cancer tumorigenesis through direct phosphorylation of JAB1

  2021cites this paper
• Signaling of MK2 sustains robust AP1 activity for triple negative breast cancer tumorigenesis through direct phosphorylation of JAB1

  2021cites this paper
• NT157 Inhibits HCC Migration via Downregulating the STAT3/Jab1 Signaling Pathway

  2021cites this paper
• Jab1/Cops5: a promising target for cancer diagnosis and therapy

  2021cites this paper
• The potential oncogenic and MLN4924-resistant effects of CSN5 on cervical cancer cells

  2021cites this paper
• Jab1 promotes gastric cancer tumorigenesis via non-ubiquitin proteasomal degradation of p14ARF

  2020cites this paper
• Long non-coding RNA KRT19P3 suppresses proliferation and metastasis through COPS7A-mediated NF-κB pathway in gastric cancer

  2019cites this paper
• The pivotal oncogenic role of Jab1/CSN5 and its therapeutic implications in human cancer.

  2019cites this paper
• The Interaction between Methionine Sulfoxide Reductase A and Csn5/Jab1

  2019cites this paper
• Jab1/Cops5 contributes to chemoresistance in breast cancer by regulating Rad51.

  2019cites this paper
• COP9 signalosome complex subunit 5, an IFT20 binding partner, is essential to maintain male germ cell survival and acrosome biogenesis†

  2019cites this paper
• hsa-miR-24 suppresses metastasis in nasopharyngeal carcinoma by regulating the c-Myc/epithelial-mesenchymal transition axis

  2018cites this paper
• JAB1 regulates CPNE1-related differentiation via direct binding to CPNE1 in HiB5 hippocampal progenitor cells.

  2018cites this paper
• Jab1/COPS5 as a Novel Biomarker for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Human Cancer

  2018cites this paper
• COPS5 and LASP1 synergistically interact to downregulate 14‐3‐3σ expression and promote colorectal cancer progression via activating PI3K/AKT pathway

  2018cites this paper
• CSN5/Jab1 facilitates non-small cell lung cancer cell growth through stabilizing survivin.

  2018cites this paper
• Musa paradisiaca inflorescence induces human colon cancer cell death by modulating cascades of transcriptional events.

  2018cites this paper
• COP9 signalosome subunit 5 regulates cancer metastasis by deubiquitinating SNAIL

  2018cites this paper
• Improved detection of gene-microbe interactions in the mouse skin microbiota using high-resolution QTL mapping of 16S rRNA transcripts

  2017cites this paper
• Roles of Multifunctional COP9 Signalosome Complex in Cell Fate and Implications for Drug Discovery

  2017cites this paper
• CSN5 promotes renal cell carcinoma metastasis and EMT by inhibiting ZEB1 degradation.

  2017cites this paper
• Analysis of differential gene expression profile identifies novel biomarkers for breast cancer

  2017cites this paper
• Increased Jab1/COPS5 is associated with therapeutic response and adverse outcome in lung cancer and breast cancer patients

  2017cites this paper
• Jab1/Csn5 Signaling in Breast Cancer Jab1/Csn5 Signaling in Breast Cancer

  2017cites this paper
• Jab1/Csn5 Signaling in Breast Cancer

  2017cites this paper
• Functional Role of the COP9 Signalosome in Colorectal Cancer and Intestinal Homeostasis:Mechanistic Links to Cancerogenic Signaling Pathways in the Gut

  2017cites this paper
• CSN5/JAB1 suppresses the WNT inhibitor DKK1 in colorectal cancer cells.

  2017cites this paper
• Development of evidence based novel synbiotic components for the prevention and management of lifestyle associated diseases

  2016cites this paper
• The emerging roles of Jab1/CSN5 in cancer

  2016cites this paper
• Down‐regulation of the cyclin‐dependent kinase inhibitor p57 is mediated by Jab1/Csn5 in hepatocarcinogenesis

  2016cites this paper
• Stat3 Contributes to Cancer Progression by Regulating Jab1/Csn5 Expression

  2016cites this paper
• COPS5 amplification and overexpression confers tamoxifen-resistance in ERα-positive breast cancer by degradation of NCoR

  2016cites this paper
• Direct binding of Copine3 with Jab1 activates downstream ErbB2 signaling and motility in SKBr3 breast cancer cells.

  2016cites this paper
• Jab1 promotes glioma cell proliferation by regulating Siah1/β-catenin pathway

  2016cites this paper
• The Role of the COP9 Signalosome and Neddylation in DNA Damage Signaling and Repair

  2015cites this paper
• Role of the COP9 Signalosome in Gastrointestinal Cancers

  2015cites this paper
• Biomarkers for enhancing the radiosensitivity of nasopharyngeal carcinoma

  2015cites this paper
• Direct binding of Copine 3 with Jab 1 activates downstream ErbB 2 signaling and motility in SKBr 3 breast cancer cells

  2015cites this paper
• Suppression of CSN5 promotes the apoptosis of gastric cancer cells through regulating p53-related apoptotic pathways.

  2015cites this paper
• Emerging roles of Jab1/CSN5 in DNA damage response, DNA repair, and cancer

  2014cites this paper
• Exploiting Cell Cycle Pathways in Cancer Therapy: New (and Old) Targets and Potential Strategies

  2014cites this paper
• Decreased expression and prognostic role of cytoplasmic BRSK1 in human breast carcinoma: correlation with Jab1 stability and PI3K/Akt pathway.

  2014cites this paper
• Expressão imuno-histoquímica das proteínas Jab1, p27, c-jun e c-fos no adenoma pleomórfico, adenocarcinoma polimorfo de baixo grau e carcinoma adenoide cístico das glândulas salivares

  2014cites this paper
• JAB1 NEGATIVELY REGULATES PTEN AND PROMOTES RESISTANCE TO TRASTUZUMAB IN HER2-POSITIVE BREAST CANCER

  2014cites this paper
• The β-catenin E3 ubiquitin ligase SIAH-1 is regulated by CSN5/JAB1 in CRC cells.

  2014cites this paper
• Dynamic Changes of Jab1 and p27kip1 Expression in Injured Rat Sciatic Nerve

  2013cites this paper
• Thioredoxin-mediated redox regulation of resistance to endocrine therapy in breast cancer.

  2013cites this paper
• JAB1 regulates unphosphorylated STAT3 DNA-binding activity through protein-protein interaction in human colon cancer cells.

  2013cites this paper
• The expression and significance of FOXO3a and Jab1 in human ovarian cancer

  2013cites this paper
• Adhesion to fibronectin induces p27Kip1 nuclear accumulation through down-regulation of Jab1 and contributes to cell adhesion-mediated drug resistance (CAM-DR) in RPMI 8,226 cells

  2013cites this paper
• Jun activation domain-binding protein 1 expression in oral squamous cell carcinomas inversely correlates with the cell cycle inhibitor p27

  2012cites this paper
• An essential role of p 27 downregulation in fenvalerate-induced cell growth in human uterine leiomyoma and smooth muscle cells

  2012cites this paper
• Dynamic changes of PIRH2 and p27kip1 expression in injured rat sciatic nerve

  2012cites this paper
• Expressão imunohistoquímica das proteínas c-Jun não fosforilada/fosforilada e p27 em leucoplasias de pacientes fumantes e não fumantes

  2012cites this paper
• An essential role of p27 downregulation in fenvalerate-induced cell growth in human uterine leiomyoma and smooth muscle cells.

  2012cites this paper
• Hypoxia-inducible factor 1 promoter-induced JAB1 overexpression enhances chemotherapeutic sensitivity of lung cancer cell line A549 in an anoxic environment.

  2012cites this paper
• Jab1/CSN5 negatively regulates p27 and plays a role in the pathogenesis of nasopharyngeal carcinoma.

  2012cites this paper
• Huntingtin with an expanded polyglutamine repeat affects the Jab1-p27(Kip1) pathway.

  2012cites this paper
• Hypoxia-Inducible Factor 1 Promoter-Induced JAB 1 Overexpression Enhances Chemotherapeutic Sensitivity of Lung Cancer Cell Line A 549 in an Anoxic Environment

  2012cites this paper
• Role of CSN5/JAB1 in Wnt/β‐catenin activation in colorectal cancer cells

  2012cites this paper
• Suppression of Jab1/CSN5 induces radiation- and chemo-sensitivity in nasopharyngeal carcinoma through changes to the DNA damage and repair pathways

  2012cites this paper
• Targeting Jab1/CSN5 in nasopharyngeal carcinoma.

  2012cites this paper
• Jab1/CSN5 mediates E2F dependent expression of mitotic and apoptotic but not DNA replication targets

  2011cites this paper
• Genome-Wide Local Ancestry Approach Identifies Genes and Variants Associated with Chemotherapeutic Susceptibility in African Americans

  2011cites this paper
• C10ORF97 is a novel tumor-suppressor gene of non-small-cell lung cancer and a functional variant of this gene increases the risk of non-small-cell lung cancer

  2011cites this paper
• Subunit 6 of the COP9 signalosome promotes tumorigenesis in mice through stabilization of MDM2 and is upregulated in human cancers.

  2011cites this paper
• THE COP9 SIGNALOSOME, A NOVEL, ESSENTIAL REGULATOR OF SKELETAL DEVELOPMENT AND TUMORIGENESIS.

  2011cites this paper
• Bcr‐Abl oncogene stimulates jab1 expression via cooperative interaction of β‐catenin and STAT1 in chronic myeloid leukemia cells

  2011cites this paper
• Molecular targeting of CSN5 in human hepatocellular carcinoma: a mechanism of therapeutic response

  2011cites this paper
• Potential role of Jun activation domain-binding protein 1 and phosphorylated p27 expression in prognosis of glioma

  2011cites this paper
• Stat3 and CCAAT/enhancer binding protein beta (C/EBP-beta) regulate Jab1/CSN5 expression in mammary carcinoma cells

  2011cites this paper
• Roles of COP9 signalosome in cancer

  2011cites this paper
• JAB1/CSN5: a new player in cell cycle control and cancer

  2010influential citation
• p27Kip1 as a Biomarker and Target for Treatment of Cancer

  2010cites this paper
• Expression studies on PPARγ in pancreatic neuroendocrine tumours

  2010cites this paper
• JAB1 expression is associated with inverse expression of p27(kip1) in hepatocellular carcinoma.

  2010cites this paper
• Clinicopathological Significance of Expression of Tspan-1, Jab1 and p27 in Human Hepatocellular Carcinoma

  2010cites this paper
• Essential roles of Jab1 in cell survival, spontaneous DNA damage and DNA repair

  2010cites this paper
• Jun Activation Domain Binding Protein 1 is Overexpressed from the Very Early Stages of Hepatocarcinogenesis

  2010cites this paper
• Dual role of macrophage migration inhibitory factor (MIF) in human breast cancer

  2009cites this paper
• Cytoplasmic localization of Jab1 and p27 Kip1 might be associated with invasiveness of papillary thyroid carcinoma.

  2009cites this paper
• Jab1/CSN5 induces the cytoplasmic localization and degradation of RUNX3

  2009cites this paper
• Mammalian COP9 signalosome

  2009cites this paper
• Overexpression of adenovirus-mediated p27kip1 lacking the Jab1-binding region enhances cytotoxicity and inhibits xenografted human cholangiocarcinoma growth.

  2009cites this paper
• Jab1 has negative effects on p53-mediated genotoxic stresses.

  2009cites this paper
• Significance of Jab1 Expression in Human Esophageal Squamous Cell Carcinoma

  2009cites this paper
• Expression of Jun activation domain-binding protein 1 and Ser10 phosphorylated p27 protein in human epithelial ovarian carcinoma

  2009cites this paper
• Jab1 is overexpressed in human breast cancer and is a downstream target for HER-2/neu

  2008cites this paper
• Jab1 is a target of EGFR signaling in ERα-negative breast cancer

  2008cites this paper
• Jun activation domain-binding protein 1 negatively regulate p27kip1 in non-Hodgkin’s lymphomas

  2008cites this paper
• CSN 5 Isopeptidase Activity Links COP 9 Signalosome Activation to Breast Cancer Progression

  2008cites this paper
• Jab1 is overexpressed in human breast cancer and is a downstream target for HER-2/neu.

  2008cites this paper
• CSN5 isopeptidase activity links COP9 signalosome activation to breast cancer progression.

  2008cites this paper